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Steven Fehrer, P.T., Ph.D.
107 Skaggs Bldg, 243-2429
steven.fehrer@umontana.edu
Office hours by appointment, arrange by email
Guest Speakers: Sherrill Brown, DVM, PharmD
Catherine Goodman, MBA, PT
Credits: 2
Meeting Time: 
Tuesday 10:10-11:00 AM SB 025
Thursday 10:10-11:00 AM SB 025 and SB 020
Required Text:
Goodman and Snyder. Differential Diagnosis for Physical Therapists, Screening for
Referral 4th edition, Saunders Elsevier, 2007
Ciccone, CD. Pharmacology in Rehabilitation 4th edition, F.A. Davis, 2007
Additional Resources: 
McKinnis, Fundamentals of Musculoskeletal Imaging, 2nd edition, F.A. Davis 2005
Boissonnault.  Primary Care for the Physical Therapist Examination and Triage, Saunders
Elsevier 2005.
Bio-defense modules CD
Course Description: Differential diagnosis of system pathology, including basic verbal
and physical screening, laboratory tests, and pharmacotherapeutic intervention.  
Evaluation Methods: There will be a midterm exam (40%) during the semester and a
comprehensive final examination (60%).  
Grading Scale: Grading will be as follow the policy of the School of Physical
therapy and Rehabilitation Science (see student handbook) with a  passing grade being a 
“C” and a 73 percent. All students must practice academic honesty.  Academic 
misconduct is subject to an academic penalty by the course instructor and /or disciplinary
sanction by the University. Any evidence of cheating or plagiarism will result in failure
   
   
 





   
 
 



















   
  
    
 
 
    
  
    
 







of the course. All students need to be familiar with the Student Conduct Code.  The Code
is available for review online at http://www.umt.edu/SA/VPSA/index.cfm/page1321. 
Professional Behaviors: Professional behaviors are expected in the course. These 
include (but are not limited to): responsibility for one's own learning, completion of
group and individual assignments in a timely manner, on time attendance unless excused,
coming to class prepared, treating fellow students, staff, and faculty with respect, 
receiving and giving constructive criticism when appropriate. Cell phones should be
turned off and put away. No text messaging during class. Lap top computers may be
used to take notes and when appropriate, search the web for information pertaining to the
topic being discussed in class. Other uses of personal computing devices in class are
prohibited. Please refer to the "Generic Abilities" section in your student handbook. If a
student persistently exhibits unprofessional behavior during class, they will be subject to 
disciplinary action.
Teaching Methods and Learning Experiences: The content for this course will be
presented through a lecture format and the assignment of readings. The course will also
include occasional laboratory activities addressing abdominal palpation and
cardiopulmonary testing.  A Blackboard shell has been created for the course. This shell 
will contain power point presentations, class notes, additional reference material, and
review questions.  
Schedule: 
8/26 Urogenital Clinical Medicine
Review Goodman and Snyder chapter 10
8/28 Urogenital Clinical Medicine
9/2 Urogenital Clinical Medicine
9/6 Urogenital Clinical Medicine
9/9 Pharmacotherapeutics – urogenial
Review Ciccone chapter 30
9/11 Pharmacotherapeutics - antidepresssants
Review Ciccone chapter 7
9/16 Pharmacotherapeutics – antipsychotics
Review Ciccone chapter 8
9/18 Pharmacotherapeutics – ADHD
9/23 Drug Information Sources –Dr. Sherrill Brown
9/25 Clinical Laboratory Values
Review chapter 18 - Boissonnault, Primary Care for the Physical Therapist Examination
and Triage
9/30 Clinical Laboratory Values
10/2 Clinical Laboratory Values
 









   
 
 
    
    
 
 



























10/7 Clinical Laboratory Values
End of material for midterm exam
10/9 Upper Quarter Screening
10/14 Midterm Exam
10/16 Lower Quarter Screening
10/21 Lab Abdominal Screening
10/23 Primary Care Model
Review chapter 1 - Boissonnault, Primary Care for the Physical Therapist Examination
and Triage
10/28 Primary Care Model – Triage
10/30 Primary Care Model – APTA Annual Visit to PT
11/4 Holiday no class





11/25 Basic Bio-defense modules
11/27 Holiday no class
12/2 Catherine Goodman
12/4 Catherine Goodman
Comprehensive Final Examination Monday December 8, 2008 1:00 – 3:00 PM SB 117
Objectives: 





Urogenital  Disorders 
1.1 Describe the common signs/symptoms of persons with these disorders. 
1.2 Describe the common forms of medical intervention for these disorders. Describe the
underlying pathologies for these disorders. Describe the referred pain patterns for
these disorders. 




1.1  Define primary care physical therapy and explore various practice models. 
1.2  Review primary care epidemiology and implications for physical therapy 
1.3 Describe the physical therapist’s role in screening patients with acute trauma. 
2.1  Discuss the necessary competencies to succeed in the primary care role. 
2.2 Discuss how patient assessment in acute trauma differs from other situations. 
2.3 Identify settings/situations where physical therapists may need to perform an acute 
trauma assessment. 
2.4 Discuss how the findings of a primary and secondary survey influence physical 
therapy intervention. 
2.5 Discuss appropriate trauma management. 
2.6 Discuss the various types of shock and their effects as well as methods to treat them. 
 
Screens and Laboratory Values 
1.1  Become familiar with laboratory values that are pertinent to clients receiving 
physical therapy.  Address the significant health consequences that may occur if they are 
not considered. 
1.2 Become familiar with laboratory tests that may be pertinent in formulating a 
diagnosis and treatment plan, and refer to primary care appropriately. 
1.3 Become familiar with appropriate questions when obtaining a client history to help 
identify any underlying disease process(es) that warrants referral to primary care.   
2.1 Consider differential diagnoses when developing treatment plans, keeping in mind 
possible underlying disease that may mimic more ‘strait-forward’ musculoskeletal or 
neurological disease/processes. 
2.2 Recognize that a thorough history helps to guide the clinician in the appropriate 
physical exam. 
5.1 Prepare the DPT student for a direct access environment. 
 
Pharmacotherapeutics 
1.1  Describe clinical considerations germane to physical therapist practice of commonly 
prescribed medications. 
1.2  Identify valuable clinical sources of drug information. 
1.3  Describe the primary objectives of the upper and lower quarter screening 
examination related to the differential diagnosis process. 
1.4  Explain the relevance of each of the specific examination elements as they relate to 
the differential diagnosis process, including identification of clinical red flags that would 
result in a patient referral or consultation. 
2.1 Apply the principles of patient screening to the subject of pharmacovigilance. 
 
Differential diagnosis and screening for cancer 
1.1 Identify 4 ways cancer metastasizes. 
1.2 Name the most common risk factors for cancer 
    
 
   
 
   
1.3 Name the 4 systems most often affected by cancer metastasis in a physical therapist
practice.
1.4 Describe a least two of the corresponding clinical manifestations of each system
affected by cancer metastasis.
1.5 List 5 clinical signs and symptoms corresponding to paraneoplastic syndromes.
